An Independent Investment Company
Strategic investing at the intersection of science, technology, and human potential.
Koenig Ventures LLC is dedicated to discovering and scaling transformative technologies that redefine industries and improve lives. Our mission is to connect capital with creativity—bridging innovation in biotech, quantum computing, and advanced materials with practical execution and long-term value creation.
Investing in companies developing novel therapies, biologics, and AI-driven drug discovery platforms that address critical unmet needs.
Scaling innovations in composites, energy storage, and sustainable infrastructure—building the physical backbone of tomorrow’s economy.
Bridging computation and cognition through AI-native and quantum-ready architectures designed to enhance valuation, modeling, and decision systems.
Targeting asymmetric opportunities in restructuring, spinouts, and cross-market arbitrage where insight and timing matter most.
Targeting asymmetric opportunities in satellite infrastructure, defense-linked space systems, and emerging commercial platforms that are redefining global communications, security, and data networks.
Share a thought or question with Koenig Ventures — we value your ideas and dialogue.
Koenig Ventures LLC is a privately held venture investment and advisory firm founded by Steven G. Koenig. The firm brings together finance, science, technology, and strategic leadership to identify asymmetric, long-term investment opportunities across global markets.
Steven has nearly four decades of experience spanning institutional finance, derivatives trading, risk management, venture capital, executive leadership, and higher education. Before founding Koenig Ventures, he spent 24 years in global financial markets, including serving as a Managing Director and Co-Head of Global Latin American Sales and Derivatives Trading at J.P. Morgan. During his career, he worked with corporations, financial institutions, governments, and institutional investors on complex financial instruments, market risk, capital allocation, and cross-border strategy.
Following his Wall Street career, Steven served as a Professor of the Practice at the University of Kansas School of Business, where he taught graduate-level courses in derivatives, risk management, and international finance. His academic and professional background continues to shape the firm’s disciplined approach to investment analysis, valuation, scenario modeling, and downside-risk management.
Through Koenig Ventures, Steven has invested in and advised businesses operating across biotechnology, artificial intelligence, quantum computing, advanced materials, telecommunications infrastructure, space technology, consumer products, and other emerging industries. He has worked closely with founders, scientists, executives, attorneys, and investors on matters including corporate strategy, financing, commercialization, organizational design, leadership development, and long-term value creation.
Steven is a graduate of the MIT Sloan Advanced Management Program and holds Affiliate Alumni status with the MIT Sloan School of Management. His recent executive education has included extensive work in artificial intelligence, biotechnology and pharmaceuticals, economics, systems thinking, supply-chain management, global manufacturing, entrepreneurship, organizational leadership, and emerging space markets. He continues to pursue advanced studies through MIT Sloan Executive Education and MIT xPRO.
Koenig Ventures combines the analytical discipline of institutional finance with the curiosity and long-term perspective required to invest in transformational businesses. The firm seeks opportunities where exceptional leadership, differentiated technology, strong intellectual property, and expanding global markets can converge to create enduring value.
Market insights, research notes, and perspectives from Steven G. Koenig.
Interested in connecting or sharing an idea? Reach out to us: